Compare LRE & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LRE | NAII |
|---|---|---|
| Founded | 2001 | 1980 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5M | 21.2M |
| IPO Year | 2023 | 1987 |
| Metric | LRE | NAII |
|---|---|---|
| Price | $1.43 | $4.83 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 61.8K | 15.2K |
| Earning Date | 07-30-2015 | 02-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.27 | N/A |
| EPS | ★ 0.43 | N/A |
| Revenue | $130,601,512.00 | ★ $134,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.58 | ★ N/A |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $1.00 | $2.57 |
| 52 Week High | $2.97 | $4.96 |
| Indicator | LRE | NAII |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 56.59 |
| Support Level | $1.40 | $4.43 |
| Resistance Level | $1.69 | $4.83 |
| Average True Range (ATR) | 0.18 | 0.26 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 30.16 | 52.36 |
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.